Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 09/22 08:33:31 am
41.723 EUR   +0.60%
08:25aFRESENIUS SE : Berenberg reaffirms its Buy rating
MD
05:20aFRESENIUS SE : Gets a Buy rating from Goldman Sachs
MD
09/21FRESENIUS SE : DZ Bank reaffirms its Buy rating
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
40.825(c) 40.9(c) 40.495(c) 41.475(c) 41.7 Last
964 382 2 642 741 1 216 508 1 098 552 401 096 Volume
-0.16% +0.18% -0.99% +2.42% +0.54% Change
More quotes
Estimated financial data (e)
Sales 2021 37 433 M 43 913 M 43 913 M
Net income 2021 1 818 M 2 133 M 2 133 M
Net Debt 2021 22 787 M 26 731 M 26 731 M
P/E ratio 2021 12,7x
Yield 2021 2,07%
Sales 2022 39 426 M 46 251 M 46 251 M
Net income 2022 2 066 M 2 424 M 2 424 M
Net Debt 2022 20 309 M 23 825 M 23 825 M
P/E ratio 2022 11,2x
Yield 2022 2,29%
Capitalization 23 145 M 27 121 M 27 151 M
EV / Sales 2021 1,23x
EV / Sales 2022 1,10x
Nbr of Employees 312 734
Free-Float 73,1%
More Financials
Company
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion... 
More about the company
Ratings of Fresenius SE & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about FRESENIUS SE & CO. KGAA
08:25aFRESENIUS SE : Berenberg reaffirms its Buy rating
MD
05:20aFRESENIUS SE : Gets a Buy rating from Goldman Sachs
MD
09/21FRESENIUS SE : DZ Bank reaffirms its Buy rating
MD
09/20FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Sell rating from Jefferies
MD
09/20PRESS RELEASE : Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific O..
DJ
09/17FRESENIUS : Bank of America – Global Healthcare Conference (PDF, 5.96 MB)
PU
09/17FRESENIUS MEDICAL CARE : Selects JMS Co. as Distributor of Home Dialysis Systems in Japan
MT
09/17FMC FRESENIUS MEDICAL CARE AG & CO K : Sell rating from Jefferies
MD
09/10European ADRs Move Higher in Friday Trading
MT
09/10European stocks end ECB week lower after stimulus slows as expected
RE
09/10FRESENIUS SE : Barclays reiterates its Buy rating
MD
09/10FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays gives a Neutral rating
MD
09/10FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Sell rating
MD
08/31EAGLE PHARMACEUTICALS : Granted Additional Patent for Leukemia Medication Bendamustine
MT
08/31DGAP-NVR : Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the Germa..
DJ
More news
News in other languages on FRESENIUS SE & CO. KGAA
09/217 ERKENNTNISSE über die DAX-Aufsichtsräte
09/20Rentschler Biopharma beruft Dr. Christian Schetter zum Chief Scientific Officer und stä..
09/20Börse Frankfurt-News: Im Schatten der Inflation (Anleihen)
09/17Fresenius Medical Care choisit JMS Co. comme distributeur de systèmes de dialyse à domi..
09/15Aktien Frankfurt: Dax weiter träge
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 41,48 €
Average target price 49,88 €
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter MŘller Independent Member-Supervisory Board